Nathalie Ledee | Medicine and Health Sciences | Innovative Research Award

Published on by Top Teachers

Innovative Research Award

Nathalie Lédée
MatriceLAB Innove, France

Nathalie Lédée
Affiliation MatriceLAB Innove
Country France
Scopus ID 6603321197
Documents 94
Citations 3,407
h-index 33
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-3166-2643

Nathalie Lédée, M.D., Ph.D., affiliated with MatriceLAB Innove, France, is a physician-scientist whose work has contributed to the advancement of reproductive medicine, reproductive immunology, embryo implantation biology, and assisted reproductive technologies (ART). Her academic and professional career combines clinical leadership, translational research, biotechnology innovation, and scientific mentorship. She has served in senior research and healthcare leadership positions while maintaining an active publication record and developing patented technologies aimed at improving implantation success and fertility outcomes.[1][2]

Abstract

This article summarizes the academic, clinical, and scientific achievements of Nathalie Lédée, a French physician-scientist specializing in reproductive medicine and reproductive immunology. Her research has focused on understanding immune tolerance, cytokine regulation, embryo implantation mechanisms, and biomarker-guided fertility treatments. Through leadership roles in academia, healthcare institutions, and biotechnology innovation, she has contributed to translational approaches that connect laboratory discoveries with clinical reproductive care. Her scientific output, patents, and international collaborations have influenced contemporary research in embryo implantation and assisted reproduction.[1][3]

Keywords

Reproductive Medicine; Reproductive Immunology; Embryo Implantation; Assisted Reproductive Technology; IVF; Cytokines; Fertility Research; Translational Medicine; Biomarkers; Endometrial Immune Profiling; Clinical Research; Human Reproduction.

Introduction

Nathalie Lédée obtained her Doctor of Medicine degree from the University Paris VI in 1993, completed a Master of Science at McGill University in Canada in 1995, and earned a Ph.D. in reproductive immunology in 2003. Her academic development was complemented by clinical training in obstetrics, gynecology, and reproductive medicine. Throughout her career she has pursued the integration of fundamental immunological discoveries into practical fertility treatments and patient-centered reproductive care.[1]

Her professional activities have included appointments as assistant professor, senior investigator at INSERM research units, invited professor at the University of Liège, head of reproductive medicine centers, and president of MatriceLab Innove. These positions enabled her to contribute to multidisciplinary initiatives linking clinical medicine, biotechnology innovation, and translational research.[2]

Research Profile

Nathalie Lédée’s research centers on the immunological events occurring during embryo implantation and early pregnancy. Her investigations have examined maternal-fetal dialogue, cytokine regulation, immune tolerance, uterine receptivity, and biomarkers associated with reproductive success. She has emphasized translational methodologies designed to improve embryo selection, implantation outcomes, and personalized reproductive therapies.[3]

  • Reproductive Medicine and Fertility Care
  • Reproductive Immunology
  • Embryo Implantation Biology
  • Assisted Reproductive Technologies (ART)
  • Endometrial Immune Profiling
  • Biomarker Discovery and Validation
  • Cytokine Biology
  • Translational Clinical Research

Research Contributions

Among her recognized scientific contributions is the development of immune-based approaches for evaluating uterine receptivity and implantation potential. Her work has advanced understanding of how cytokine balance and local immune regulation influence successful embryo implantation and pregnancy outcomes.[3]

She is also inventor of patented technologies addressing embryo implantation and oocyte selection. These innovations seek to improve clinical decision-making within IVF and ART programs by introducing objective biological markers into reproductive treatment pathways.[4]

  • Patent PCT WO-2008/009705 involving granulocyte colony-stimulating factor (G-CSF) assessment in follicular fluid.
  • Patent PCT/EP2013/065355 concerning methods for increasing implantation success in assisted reproduction.
  • Leadership of translational fertility research programs connecting laboratory findings to patient care.
  • Contributions to European and international reproductive medicine networks.

Publications

Nathalie Lédée has authored influential studies in reproductive immunology and embryo implantation, including randomized trials on endometrial immune profiling and precision therapy that improved live birth outcomes after embryo transfer.[3] Her work further explored uterine immune profiling in assisted reproductive technology, advancing personalized fertility care.[4] Additional contributions include research on sperm microRNA expression and fertility biomarkers,[5] immune predictors of recurrent miscarriage and therapeutic outcomes,[6] and the role of interleukin-18 in predicting embryo transfer success.[7]

Research Impact

The research record of Nathalie Lédée includes 94 indexed documents, more than 3,407 citations, and an h-index of 33. These indicators reflect sustained scholarly engagement within reproductive medicine and reproductive immunology. Her publications have addressed clinically relevant challenges including implantation failure, recurrent miscarriage, immune biomarkers, and fertility treatment optimization.[1]

Her contributions have been recognized through competitive grants, scientific awards, international fellowships, leadership positions in European research initiatives, and memberships in major professional societies including ESHRE, the American Society of Reproductive Immunology, and European reproductive medicine organizations.[2]

Award Suitability

The nomination of Nathalie Lédée for the Innovative Research Award may be considered on the basis of her long-standing contributions to reproductive medicine, translational immunology, fertility innovation, and clinical leadership. Her work demonstrates a sustained commitment to developing evidence-based approaches that improve reproductive outcomes and expand scientific understanding of embryo implantation biology.[3][4]

Additional factors supporting recognition include internationally patented inventions, leadership in fertility centers, successful integration of biotechnology innovation into healthcare practice, and publication of influential research addressing major challenges in assisted reproduction.[4][5]

Conclusion

Nathalie Lédée has established a distinguished career at the intersection of clinical reproductive medicine, reproductive immunology, and translational biomedical innovation. Through academic research, leadership of fertility programs, biotechnology entrepreneurship, and development of novel diagnostic and therapeutic strategies, she has contributed to advancements in understanding and improving human reproduction. Her body of work represents a notable example of translational science applied to reproductive healthcare.[1][3]

References

  1. Elsevier. (n.d.). Scopus author details: Nathalie Lédée, Author ID 6603321197. Scopus. https://www.scopus.com/authid/detail.uri?authorId=6603321197
  2. ORCID. (n.d.). Nathalie Lédée – ORCID Research Profile. https://orcid.org/0000-0002-3166-2643
  3. Lédée, N., Petitbarat, M., Dray, G., Chevrier, L., Kazhalawi, A., Rahmati, M., et al. (2025). Endometrial immune profiling and precision therapy increase live birth rate after embryo transfer: a randomised controlled trial. Frontiers in Immunology. DOI: https://doi.org/10.3389/fimmu.2025.1523871
  4. Lédée, N., Petitbarat, M., Prat-Ellenberg, L., Dray, G., Vaucoret, V., Kazhalawi, A., et al. (2023). The Next Frontier in ART: Harnessing the Uterine Immune Profile for Improved Performance. International Journal of Molecular Sciences. https://www.mdpi.com/1422-0067/24/14/11322
  5. Cassuto, N.G., Lédée, N., Boitrelle, F., Mouik, H., Larue, L., Keromnes, G., et al. (2025). Genome-Wide microRNA Expression Profiling in Human Spermatozoa and Its Relation to Sperm Quality. Genes. https://www.mdpi.com/2073-4425/16/1/53
  6. Kolanska, K., Lédée, N., Dabi, Y., Dechartres, A., et al. (2021). Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth. American Journal of Reproductive Immunology. https://onlinelibrary.wiley.com/doi/abs/10.1111/aji.13425
  7. Ledee-Bataille, N., Olivennes, F., Kadoch, J., Dubanchet, S., Frydman, N., Chaouat, G., & Frydman, R. Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer. Human Reproduction. DOI: https://doi.org/10.1093/humrep/deh356

Song Guo Zheng | Medicine and Health Sciences | Best Innovator Award

Published on by Top Teachers

Best Innovator Award

Song Guo Zheng
Shanghai Jiao Tong University, China
Song Guo Zheng
Affiliation Shanghai Jiao Tong University
Country China
Scopus ID 7403146499
Documents 262
Citations 16,675
h-index 75
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-5611-4774
Google Scholar 37kvQ18AAAAJ

Song Guo Zheng is a physician-scientist and immunologist whose academic career has spanned molecular immunology, rheumatology, autoimmunity, cell therapy, and translational medicine. His research has contributed to the understanding of regulatory T cells, immune tolerance, autoimmune disease mechanisms, and therapeutic immunomodulation. He currently serves as Chair Professor of Medicine and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University School of Medicine while maintaining extensive leadership roles in international scientific organizations and scholarly publishing.[1]

Abstract

This article evaluates the academic achievements, scientific leadership, educational service, and innovation record of Song Guo Zheng in relation to the Best Innovator Award. His work integrates fundamental immunology with translational medicine, resulting in influential publications, patents, edited books, international collaborations, and leadership positions across major scientific societies. The breadth of his contributions demonstrates sustained impact on biomedical research and clinical immunology.[1]

Keywords

Rheumatology, Immunology, Autoimmunity, T Regulatory Cells, Cell Therapy, GMSC, Tumor Immunity.

Introduction

Over several decades, Song Guo Zheng has established an interdisciplinary research program focused on immune regulation, autoimmune disease pathogenesis, regenerative medicine, and therapeutic cell engineering. His academic development includes medical training in China, doctoral education in France, and faculty appointments at major institutions in the United States and China. His scientific output has contributed to both theoretical and applied aspects of immunological science.[1]

Research Profile

Song Guo Zheng earned an M.D. from Anhui Medical University and later completed a Ph.D. in Molecular Immunology at the University of Orleans, France. His academic appointments have included leadership roles at the University of Southern California, Penn State University, Ohio State University, and Shanghai Jiao Tong University. He has also served as editor, associate editor, and editorial board member for numerous high-impact journals while participating in major international grant-review panels and scientific committees.[1]

Research Contributions

  • Advanced understanding of regulatory T-cell biology and immune tolerance mechanisms.[2]
  • Developed strategies for immune modulation relevant to autoimmune disorders and inflammatory diseases.[3]
  • Contributed to translational research in cell therapy, tumor immunity, and regenerative medicine.
  • Secured multiple granted patents involving regulatory T cells, exosome applications, and immunotherapeutic technologies.[1]
  • Edited scientific books and chapters that support education and dissemination of immunological knowledge.

Publications

Representative publications include influential studies on regulatory T-cell induction, immune tolerance, vitamin-mediated immune regulation, and chronic disease immunobiology. These works have become widely cited within immunology and rheumatology literature.[2][3][4][5][6]

Research Impact

According to the provided scholarly metrics, the researcher has produced 262 indexed documents, accumulated more than 16,675+ citations, and achieved an h-index of 75. These indicators reflect substantial scholarly visibility and influence within biomedical sciences. His leadership in international societies, conference organization, editorial service, and research mentoring further extends the impact of his work beyond publication metrics alone.[1]

Award Suitability

The Best Innovator Award recognizes individuals who demonstrate sustained innovation, measurable research impact, educational leadership, and translational achievement. Song Guo Zheng’s portfolio includes pioneering immunological discoveries, numerous patents, extensive publication activity, scientific leadership, international recognition, and contributions to medical education. These accomplishments collectively support strong consideration for recognition within innovation-focused academic award programs.[1]

Conclusion

Song Guo Zheng has developed a distinguished career characterized by innovation in immunology, leadership in academic medicine, and contributions to translational biomedical research. His scientific achievements, educational service, publication record, patents, and international professional engagement provide a substantial foundation for recognition under the Best Innovator Award framework.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Song Guo Zheng, Author ID 7403146499. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7403146499
  2. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity. The Journal of Immunology. https://doi.org/10.4049/jimmunol.172.9.5213
  3. Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of Vitamin A in the Immune System. Journal of Clinical Medicine. https://doi.org/10.3390/jcm7090258
  4. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.178.4.2018
  5. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation Ex Vivo of TGF-β-Producing Regulatory T Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.169.8.4183
  6. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and Chronic Diseases. Aging and Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC5440113/